Specific immunity against Yersinia was induced by plasmidencoded antigens not associated with virulence. Mice were immunised with viable bacteria from a virulence-plasmid-cured strain of Y . pseudotuberculosis. This antigenic stimulation generated specific protection against virulence-plasmid-harbouring strains of Y . pseudotuberculosis and Y. pestis, demonstrating that protection can be generated by organisms lacking plasmid-encoded virulence antigens.
INTRODUCTION
Infection with highly virulent strains of Yersinia pestis, Y . pseudotuberculosis or Y . enterocolitica induces rapid bacterial growth in organs of infected animals, with tissue invasion often producing multiple abcesses and ultimately causing death in almost all infected animals (Walker et al., 1953; Carter and Collins, 1974; Berche and Carter, 1982; Simonet et al., 1983) . It is generally believed that bacterial dissemination proceeds from primary intracellular multiplication within host macrophages (Cavanaugh and Randall, 1959; Janssen et al., 1963) . There is strong evidence that a family of plasmids, of mol. wt 42-48 x lo6 and closely related on the basis of DNA hybridisation homologies, are essential for the expression of the pathogenicity of yersiniae (Gemski et al., 1980a and b; Ben-Gurion and Shafferman, 1981; Portnoy and Falkow, 198 1 ; Portnoy et al., 198 1) . Loss of these plasmids is associated with loss of virulence and virulence can be restored by plasmid transfer into an avirulent strain (Portnoy et al., 1983) . These virulence plasmids code for temperature-dependent outer membrane proteins (Portnoy et al., 1981; Straley and Brubaker, 1981; Bolin et al., 1982; Portnoy et al., 1984) and other protein-lipoprotein complexes, called "VW" antigens Bacon, 1956 and 1960; Carter et al., 1980) . The role of these plasmid-encoded determinants in the mechanisms of pathogenicity remains obscure, as does the capacity of these antigens to confer protection.
In this study, the ability of micro-organisms to synthesise protective antigens was investigated by immunising mice with a plasmid-cured strain. This allowed evaluation of the capacity of non-plasmid-encoded antigens to induce specific protection against various highly virulent strains of Yersinia. This was achieved by using as a model a strain of Y. pseudotuberculosis cured of a 47x 106-mol. wt plasmid that was still
RESULTS
To induce protection against Yersinia, mice were each given iv inocula of lo4 cfu of Y. pseudotuberculosis strain 2637b. All the mice survived for 2 months, at which time, no viable bacteria were detected in their tissues.
On day 60, specific acquired resistance was estimated by challenging the immunised mice with 10-20 LD50 of Y . pseudotuberculosis strain 2637 (lo3 cfu/mouse, iv), Y. pestis strain 6/69 M (1.6 x lo2 cfu/mouse, sc), Y. enterocolitica strain WA (lo4 cfu/mouse, iv), and L. monocytogenes strain EGD (5 x lo5 cfu/mouse, iv). Survival of immunised and control mice was compared 21 days after challenge challenge immunised mice were significantly resistant to infection with Y. pseudotuberculosis strain 2637 (100% survival; p < 0.001) and Y. pestis strain 6/69M (50% survival; p = 0.03). In contrast, there was no significant protection against Y. enterocolitica (p = 0.98) or L. monocytogenes (p = 0-30). These results were confirmed by assessing bacterial growth in the spleen of control and immune mice, 48 h after challenges with lethal doses of the three virulent strains of Yersinia (fig. 2) . Growth of Yersinia was rapid in control mice, as indicated by the bacterial counts ranging from loglo 5.5-lOglo 6-3 cfu/spleen. On the other hand, it was not possible to detect viable bacteria in the spleen of immune mice challenged with Y. pseudotuberculosis (< lo2 cfu). When infected with Y. pestis, three out of five immune mice were capable of destroying this pathogen (< lo2 cfu), whereas bacterial growth was observed in two mice (c. lo6 cfu). With regard to the resistance of immune mice to Y. enterocolitica, the number of bacteria in the spleen was not significantly different from that in control mice (loglo 5.6 cfu). Moreover, no difference in bacterial growth was found between control and immune mice when these animals were infected with the unrelated pathogen L. monocytogenes (loglo 6-7 cfu).
DISCUSSION
These experiments show that mice immunised with a strain of Y. pseudotuberculosis cured of its virulence plasmid were protected against lethal infection by the homologous highly virulent plasmid-harbouring strain and also against the closely related pathogen Y. pestis, though to a lesser extent. This acquired resistance was demonstrated by day 60 after immunisation. Since no viable bacteria were detected in host tissues it may be assumed that immunised mice were completely cured of active infection by that time. This is important because it has been demonstrated that "avirulent" strains of Y. pestis used as live vaccines persist in the host tissue (Otten, 1936; Girard and Radaody-Ralarosy, 1940; Jawetz and Meyer, 1944 ) and consequently may maintain a long-lasting state of non-specific immunity. Furthermore, the specificity of protection induced by strain 2637b was confirmed by the absence of crossprotection against an antigenically unrelated pathogen, L. monocytogenes, and even against Y. enterocolitica, a related microorganism which shares about 50% DNA sequence homology with Y. pestis (Brenner et al., 1976) . Our data therefore bring evidence that antigens not encoded by the virulence plasmid are able to induce specific immunity against Y. pseudotuberculosis and Y. pestis.
This conclusion is consistent with previous reports that determinants not encoded on plasmids are immunogenic in animals. Indeed, resistance against plague can be generated by Y. pestis strains lacking plasmid-encoded VW virulence antigens and by "Fraction I", a chromosome-encoded capsular antigen (Burrows and Bacon, 1958; Brubaker, 1979) . That acquired resistance was induced by a Y. pseudotuberculosis strain of low virulence is also consistent with the observation that avirulent strains of Y. pestis can be used as live vaccines in man and animals (Girard and Robic, 1936; Chen and Meyer, 1955) . However, the presence of plasmids and the specificity of protection have not been documented with these strains.
The immunising strain 2637b used in this work was capable of growing in tissue, but did not become disseminated in tissues or produce abscesses (Simonet et al., 1984) . It is known that some "avirulent" strains of Y. pestis or Y. pseudotuberculosis, which probably lack virulence plasmids, survive and even multiply in macrophages (Janssen and Surgalla, 1969; Richardson and Harkness, 1970; Straley and Harmon, 1984a and b) . This suggests that the initial growth in macrophages might be due to non-plasmid encoded virulence factors and that the plasmid-encoded factors would intervene after this early stage of bacterial multiplication. The present results clearly indicate that this initial bacterial multiplication in vivo is sufficient to initiate specific immune mechanisms of resistance. It is not excluded that plasmid-encoded antigens also play a role in protective immunity, because it has recently been observed that rabbit antiserum against partially-purified V antigen protects mice against virulent strains of yersiniae (Une and Brubaker, 1984) . However, the exact nature of the protective antigens remains to be determined by studies with highly purified fractions.
